Citations

Clear

3032 citation(s) found for "Ma, Kevin".

Primary Amenorrhea: Diagnostic Approach, Imaging Spectrum, and Common Pitfalls
Trila, Maria Florencia , Mac Allister, Kevin K , Aineseder, Martina , Gomez, Erin N , Ainsworth, Alessandra J. , Jha, Priyanka , Kreindel, Tamara G , Poder, Liina , Causa Andrieu, Pamela

Mayo Clinic

RadioGraphics | November 12, 2026 | Volume: 46 | Issue: 12 | Pages: No page available

10.1148/rg.250140 | PMID 43019229 Get It

Primary amenorrhea reflects disruption along the hypothalamic-pituitary-ovarian-uterine axis; may arise from anatomic, genetic, or functional abnormalities; and may be diagnosed on the basis of US and MRI findings.
Non–Prostate Cancer‐Related Factors That Influence Serum Prostate‐Specific Antigen: A Narrative Review of 45 Non‐Malignant PSA Modifiers
Stephan, Carsten , Jung, Klaus , Sutcliffe, Siobhan , Filella, Xavier , Phillips, Michael B. , Wolinsky, Howard , Ginsburg, Kevin , Keller, David K.

Mayo Clinic

The Prostate | November 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/pros.70272 | PMID 43002634 Get It

ABSTRACT Background To consolidate into a single review more than forty non‐cancer‐related factors that have been found to elevate or reduce prostate‐specific antigen (PSA) levels in the peer‐reviewed literature, emphasizing their contribution to false‐positive and false‐negative clinical interpretations. Materials and Methods A narrative literature review was conducted using PubMed, focusing on human studies describing benign physiologic, infectious, inflammatory, iatrogenic, hormonal, pharmacologic, and laboratory‐related factors that influence PSA values. The review emphasizes contemporary studies but incorporates earlier foundational literature where relevant. Results Forty‐five non‐cancer‐related factors were identified that influence PSA values through biologic, mechanical, pharmacologic, or analytic mechanisms. Thirty factors were associated with transient or persistent PSA elevation, whereas fifteen were associated with PSA reduction. Some factors varied substantially in the strength, magnitude, and consistency of reported PSA effects across studies. PSA elevations were reported in association with prostatic inflammation or infection, urinary retention, ejaculation, non‐instrumental prostatic physical stimulation, urologic instrumentation, and systemic inflammatory conditions. PSA reductions were observed with medications including 5‐alpha‐reductase inhibitors, nonsteroidal anti‐inflammatory drugs, statins, thiazide diuretics, metformin, and certain lifestyle factors. Inter‐assay and inter‐laboratory variability alone has been reported to result in PSA differences exceeding 20%. Tables summarizing the approximate magnitude and duration of PSA change for each modifier were developed, along with a patient questionnaire intended to support, not replace, clinician judgment. Conclusion PSA interpretation must incorporate awareness of more than forty influencers that can alter PSA independent of any malignancy. Accounting for these PSA level‐altering variables can improve PSA test result specificity and enhance confidence in prostate cancer risk assessment. Use of a structured patient questionnaire, a thorough consideration of benign factors that can alter PSA, repeat testing when transient factors are present, and consistent blood assay methodology can reduce unnecessary imaging, unneeded biopsies, and missed malignancies.
Initial Diabetes Therapy After Coronary Artery Bypass Grafting and Long‐Term Outcomes
Tam, Vincy , Schaff, Hartzell V. , Thao, Viengneesee , Houten, Holly K. Van , Frye, Robert L. , Greason, Kevin L. , AlJamal, Yazan , Spencer, Philip J. , Rowse, Phillip G. , Crestanello, Juan A.

Mayo Clinic

Journal of the American Heart Association | November 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/jaha.126.053850 | PMID 42998247 Get It

ABSTRACT: Background Type 2 diabetes (T2D) is common among patients undergoing coronary artery bypass grafting (CABG), but optimal post‐CABG glucose‐lowering therapy remains uncertain. Methods We conducted a retrospective cohort study using the OptumLabs Data Warehouse of adults with T2D undergoing isolated CABG from 2012–2024. Follow‐up began 30 days after discharge. Glucose‐lowering therapy was modeled as a time‐varying exposure with patients contributing no‐observed‐therapy person‐time until the first qualifying post‐discharge fill. Pairwise comparisons used stabilized inverse probability of treatment weighting. The primary outcome was all‐cause mortality; secondary outcomes were heart failure hospitalization, stroke, and repeat coronary revascularization. Results Among 19,237 patients, 24.9% had no observed post‐discharge therapy, 42.8% received metformin, 22.9% received insulin, and 9.4% received GLP‐1RA/SGLT2i therapy. All active therapies were associated with lower mortality compared with no observed therapy, including GLP‐1RA/SGLT2i (HR 0.71, 95% CI 0.58–0.87), metformin (HR 0.60, 95% CI 0.55–0.66), and insulin (HR 0.75, 95% CI 0.67–0.84). Among active therapies, metformin was associated with lower mortality than insulin (HR, 0.61 [0.54–0.70]); GLP‐1RA/SGLT2i comparisons with metformin and insulin were less precise. Metformin was also associated with lower cumulative incidence of heart failure hospitalization than no observed therapy and insulin, and lower stroke incidence than insulin. Conclusions Observed glucose‐lowering therapy initiation after CABG was associated with lower mortality compared with no observed therapy across all active treatment groups. These findings highlight a potential care gap and suggest that proper initiation of diabetes therapy after CABG represents an important opportunity to improve long‐term outcomes following surgical revascularization.
Patient-Reported Outcomes after Robotic Resection of Deep Endometriosis of the Bowel
Addison, Poppy , Stewart, Kelsey, Garfinkle, Richard , Cope, Adela, Langstraat, Carrie , Burnett, Tatnai, Behm, Kevin

Mayo Clinic

Diseases of the Colon & Rectum | November 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/dcr.0000000000004492 | PMID 42974830 Get It

BACKGROUND: While minimally invasive surgery is the current surgical standard of care for excision of deep endometriosis of the bowel, there is little literature evaluating patient-reported outcome measures following a multidisciplinary, robotic approach. OBJECTIVE: This study aimed to assess the functional outcomes of robotic surgery for patients undergoing resection of deep endometriosis involving the bowel. DESIGN: Retrospective cohort review. SETTINGS: A single academic tertiary institution. PATIENTS: Patients with endometriosis of the bowel undergoing multidisciplinary resection between January 1, 2018, and October 1, 2023. MAIN OUTCOME MEASURES: A survey assessing functional outcomes on a Numeric Rating Scale preoperatively and at multiple points postoperatively. RESULTS: Of 92 eligible patients, 41 completed a preoperative survey and at least one postoperative survey. Among these 41 patients, overall pain improved postoperatively from 5.3 ± 2.7 (Numeric Rating Scale) to a nadir of 1.6 ± 1.9 at 6 months and 2.3 ± 3.0 at 12 months ( p < 0.001). Preoperative pain at ovulation (mean 4.2 Numeric Rating Scale ± 3.7), pre-period pain (4.9 ± 3.5), period pain (5.7 ± 3.6) and post-period pain (3.3 ± 3.3) all decreased to a mean of 1 at 12 months postoperatively ( p < 0.001). The proportion of patients reporting pain impacting work decreased from 88% preoperatively to <40% postoperatively ( p < 0.001). The proportion of patients happy with their bowel function increased from 39% preoperatively to 63.2% at 1 month, 80.0% at 6 months, and 69.2% at 12 months postoperatively ( p = 0.014). LIMITATIONS: Only 31.7% of patients responded to their 12-month survey, tertiary care center, low diversity in patient demographics, retrospective design. CONCLUSION: In this cohort of patients undergoing multi-disciplinary robotic excision for advanced endometriosis involving the bowel, patients reported significantly improved pain and quality of life measures. See Video Abstract.
Application of Optic Neuritis Diagnostic Criteria in Autoimmune Paraneoplastic CRMP5 Optic Neuropathy and Development of the “CRMP” Score
Dinoto, Alessandro , Cohen, Devon A , Cacciaguerra, Laura , Tisavipat, Nanthaya , Syc-Mazurek, Stephanie B , Lennon, Vanda A , Bhatti, M Tariq , Tajfirouz, Deena , Chodnicki, Kevin , Pittock, S J , Flanagan, E P , Chen, John J

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | October 21, 2026 | Volume: 13 | Issue: 6 | Pages: No page available

10.1212/nxi.0000000000200666 | PMID 42905998 Get It

Non-tobacco Nicotine Dependence Is Associated With Increased Perioperative Complications After Carpal Tunnel Release
Rankin, William H , Holle, Alejandro , Renfree, Kevin

Mayo Clinic

HAND | October 1, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15589447261487702 | PMID 42820380 Get It

Background: While tobacco use is a well-known risk factor for adverse outcomes after carpal tunnel release (CTR), the impact of non-tobacco nicotine products remains unclear. This study evaluated complications in CTR patients with non-tobacco nicotine dependence (NTND) compared with tobacco users and controls. Methods: Patients who underwent CTR with ≥2-year follow-up were identified using a large national database. After 1:1 propensity score matching, patients with NTND (n = 6319) were matched to controls, tobacco users (n = 86 430) were matched to controls, and patients with NTND (n = 6325) were matched to tobacco users. Matching was based on age, gender, Charlson comorbidity index, and comorbidities. Outcomes including 90-day medical complications, infection, emergency department (ED) visits, readmissions, and 2-year revision rates were compared using multivariable logistic regression. Results: Compared with controls, patients with NTND demonstrated higher 90-day medical complication rates (2.4% vs 1.7%; odds ratio [OR], 1.35; 95% CI, 1.04-1.77) and ED visits (10.3% vs 8.1%; OR, 1.16; 95% CI, 1.02-1.32). Compared with tobacco users, patients with NTND had decreased ED visits (10.4% vs 14.2%; OR, 0.74; 95% CI, 0.66-0.83) and revision surgery (1.9% vs 2.5%; OR, 0.78; 95% CI, 0.62-0.99), with no significant differences in medical complications, infection, or readmissions. Conclusions: Non-tobacco nicotine dependence was associated with increased medical complications and ED visits compared with controls, but decreased ED visits and revision surgery compared with tobacco users. There were no significant differences in medical complications, infections, or readmissions between tobacco users and patients with NTND. These findings underscore the importance of screening for non-tobacco nicotine use during preoperative evaluations for CTR.
Genomic Confirmation of HLA‐C*06:358 by Next Generation and Oxford Nanopore Sequencing
Merschman, Jarret , Gandhi, Manish , Kreuter, Justin, Millard, Kevin , Wakefield, Laurie

Mayo Clinic

HLA | September 28, 2026 | Volume: 108 | Issue: 4 | Pages: No page available

10.1111/tan.71011 | PMID 42802410 Get It

ABSTRACT The HLA‐C*06:358 allele is characterised by a single nucleotide substitution in codon 95 in exon 3.
Chemotherapy Versus Surgery for Stage IIA Nonseminomatous Germ Cell Tumor: A Comparative Cost Utility Analysis
Sharma, Vidit , Boorjian, Stephen A., Wymer, Kevin , Ratcliff, G., Penson, David F. , Leibovich, Bradley C., Costello, Brian A., Pagliaro, Lance C. , Barocas, Daniel A., Joyce, Daniel D., Boorjian, Stephen A. , Ratcliff, Grace E., Graves, John A. , Costello, Brian A. , Barocas, Daniel A.

Mayo Clinic

Journal of Urology | September 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/ju.0000000000005317 | PMID 42758859 Get It

Editorial Commentary
Mali, Kaela M., Koo, Kevin

Mayo Clinic

Urology Practice | September 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/upj.0000000000001075 | PMID 42758083 Get It

Acute Coronary Event - Return To Exercise Approach
Tayon, Kevin G. , Gutzwiller, Leah, Carlisle, Ashley E., Dineen, Elizabeth, Ali, Mays, Shapiro, Brian, Taylor, Bryan, Shapiro, Brian

Mayo Clinic

Medicine & Science in Sports & Exercise | September 18, 2026 | Volume: 58 | Issue: 10S | Pages: No page available

10.1249/01.mss.0001260200.84050.cc Get It